Showing 7571-7580 of 8649 results for "".
- Nicox’s NCX 470 Mont Blanc Phase 3 Glaucoma Trial Reaches 50% Enrollment Milestonehttps://modernod.com/news/nicoxs-ncx-470-mont-blanc-phase-3-glaucoma-trial-reaches-50-enrollment-milestone/2478999/Nicox announced that 50% of patients in the Mont Blanc NCX 470 phase 3 glaucoma clinical trial have now been randomized out of a target of 670, with topline results currently on track to be announced during Q2 2022. “We have been successful in maintaining a good recruitment rate in the Mon
- Senate Narrowly Confirms Becerra as HHS Secretaryhttps://modernod.com/news/senate-narrowly-confirms-becerra-as-hhs-secretary/2478991/The Senate has narrowly confirmed California Attorney General Xavier Becerra as secretary of the Department of Health and Human Services, according to a FierceHealthcare
- BJO Publishes New Data on Clearside Biomedical’s Investigational Treatment Xiperehttps://modernod.com/news/bjo-publishes-new-data-on-clearside-biomedicals-investigational-treatment-xipere/2478989/New data has been published in The British Journal of Ophthalmology related to the clinical development program of Clearside Biomedical’s Xipere, an investigational treatment with a proposed indication of macular edema associated with noninfectious uveitis.
- New Study Finds Significant Improvements in DED Following Use of Eye Eco Tranquileyes XL and Tranquilvibes Hydrating Maskshttps://modernod.com/news/new-study-finds-significant-improvements-in-ded-following-use-of-eye-eco-tranquileyes-xl-and-tranquilvibes-hydrating-masks/2478984/Eye Eco announced results of a study validating the clinical benefits of its moist heat masks, Tranquilvibes and Tranquileyes XL, for improving the signs and symptoms of dry eye disease caused by meibomian gland dysfunction (MGD). Patients who used the masks to treat tired, dry, gritty, inflamed
- The World Council of Optometry and CooperVision Partner to Define a Standard of Care to Treat Myopia Progressionhttps://modernod.com/news/the-world-council-of-optometry-and-coopervision-partner-to-define-a-standard-of-care-to-treat-myopia-progression/2478985/The World Council of Optometry (WCO) and CooperVision have announced a global partnership to raise awareness of myopia progression and encourage optometrists to embrace a standard of care to manage the condition. “Myopia is arguably the most widespread epidemic faced by the global optometr
- Studies Demonstrate the Efficacy and Safety of Eyenovia MAP Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasishttps://modernod.com/news/studies-demonstrate-the-efficacy-and-safety-of-eyenovia-map-fixed-combination-tropicamide-phenylephrine-product-for-mydriasis/2478982/Eyenovia announced the publication of “
- CorneaGen Names Bernie Iliakis Presidenthttps://modernod.com/news/corneagen-names-bernie-iliakis-president/2478979/CorneaGen announced that Bernardino “Bernie” Iliakis has been promoted from chief operating officer to president of the company. Mr. Iliakis will assume leadership of the company as part of Monty Montoya’s transition from CEO to strategic advisor to CorneaGen.
- Moderna Gives First Vaccine Shots To Young Kids As Part Of COVID-19 Studyhttps://modernod.com/news/moderna-gives-first-vaccine-shots-to-young-kids-as-part-of-covid-19-study/2478978/Children have now received their first doses of Moderna’s COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old, according to an NPR
- CooperVision: Clariti 1 day Becomes First Net Plastic Neutral Contact Lens in the UShttps://modernod.com/news/coopervision-clariti-1-day-becomes-first-net-plastic-neutral-contact-lens-in-the-us/2478971/To provide an easy way for eye care professionals and their patients to be more sustainable, CooperVision announced a partnership with Plastic Bank that makes its clariti 1 day family the first net plastic neutral contact lenses.1 Plastic Bank is a social enterprise that builds
- EyeYon Medical Raises $25 million in Series C to Transform Corneal Carehttps://modernod.com/news/eyeyon-medical-raises-25-million-in-series-c-to-transform-corneal-care/2478969/EyeYon Medical announced the completion of a $25 million in a Series C funding, which will be used to expand the clinical trials of EyeYon Medical’s flagship product, EndoArt. EndoArt is the first synthetic implant that enables doctors to treat chronic corneal edema with a minimally invasi